Literature DB >> 22460960

Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: controversy continues.

Kana Masuta, Yuichiro Oba, Kentaro Iwata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22460960     DOI： 10.1093/cid/cis331

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Methicillin-resistant Staphylococcus aureus-induced thrombo-inflammatory response is reduced with timely antibiotic administration.

Authors:  Zechariah Franks; Robert A Campbell; Adriana Vieira de Abreu; Jeffrey T Holloway; James E Marvin; Bjoern F Kraemer; Guy A Zimmerman; Andrew S Weyrich; Matthew T Rondina
Journal:  Thromb Haemost       Date:  2013-01-24       Impact factor: 5.249

2.  An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy.

Authors:  Richard R Watkins; Tracy L Lemonovich; Thomas M File
Journal:  Core Evid       Date:  2012-12-11

3.  Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP).

Authors:  Andrew F Shorr; Laura A Puzniak; Pinaki Biswas; Michael S Niederman
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

4.  Successful selection of an infection-protective anti-Staphylococcus aureus monoclonal antibody and its protective activity in murine infection models.

Authors:  Hiroyoshi Ohsawa; Tadashi Baba; Jumpei Enami; Keiichi Hiramatsu
Journal:  Microbiol Immunol       Date:  2015-04       Impact factor: 1.955
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.